Appendix cancer
Appendix cancer | |
---|---|
Other names | Appendiceal cancer |
Specialty | Oncology, general surgery |
Symptoms | Bloating, discomfort in lower right abdomen, shortness of breath, loss of appetite [1] |
Usual onset | ~50-55 years old [2] |
Types | Colonic-Type Adenocarcinoma, Non-carcinoid Appendix Tumors, Signet-Ring Cell Adenocarcinoma [3] |
Risk factors | Smoking, family history, Multiple endocrine neoplasia type 1 [4] |
Diagnostic method | Biopsy, CT Scan, MRI[5] |
Differential diagnosis | Acid reflux, Irritable bowel syndrome, Lactose intolerance, Stomach cancer[6] |
Treatment | Appendectomy, chemotherapy, radiation therapy [7] |
Prognosis | Five-year survival rate 25-88% (U.S.) [8] |
Frequency | ~1,000 cases per year (U.S.)[9] |
Deaths | Unknown |
Appendix cancer are very rare cancers of the vermiform appendix.
Gastrointestinal stromal tumors are rare tumors with malignant potential. Primary lymphomas can occur in the appendix. Breast cancer, colon cancer, and tumors of the female genital tract may metastasize to the appendix.[10]
Diagnosis
Carcinoid tumors are the most common tumors of the appendix.[11] Other common forms are mucinous adenocarcinoma's, adenocarcinoma-not otherwise specified (NOS), and signet ring cell adenocarcinoma listed from highest to lowest incidence.[12]
Carcinoid
A carcinoid is a neuroendocrine tumor (NET) of the intestines. Incidence rates among carcinoids occur at about .15 per 100,000 per year. This subgroup makes up a large amount of neoplasias both malignant and benign. Almost 3 out of 4 of these tumors are associated with the region at the end of the appendix, and tend to be diagnosed in the 4th to 5th decades in life. Both women and Caucasian individuals show a minor prevalence regarding Neuroendocrine tumor diagnosis without an explanation. [13] Prognosis of 5 year survival rates of carcinoids averages between 70-80% for typical cases. Advanced cases for 5 year survival range from 12-28%.
Mucinous neoplasm
Mucinous cystadenoma is an obsolete term for appendiceal mucinous neoplasm.[15]
Treatment
Small carcinoids (<2 cm) without features of malignancy may be treated by appendectomy if complete removal is possible. Other carcinoids and adenocarcinomas may require right hemicolectomy. Note: the term "carcinoids" is outdated: these tumors are now more accurately called "neuroendocrine tumors."[16]
Pseudomyxoma peritonei treatment includes cytoreductive surgery which includes the removal of visible tumor and affected essential organs within the abdomen and pelvis. The peritoneal cavity is infused with heated chemotherapy known as HIPEC in an attempt to eradicate residual disease. The surgery may or may not be preceded or followed with intravenous chemotherapy or HIPEC.[17]
Epidemiology
A study of primary malignancies in the United States found a rate of 0.12 cases per 1,000,000 population per year. Carcinoids that were not identified as malignant were not included in this data.[18] Carcinoid is found in roughly 1 in 300-400 appendectomies for acute appendicitis.[19]
In a systematic literature review where 4765 appendiceal cancer patients were identified, the incidences of appendiceal cancer were shown to have increased regardless of the type of tumor, age, sex, and stage of appendiceal cancer.[12] Roughly 75% of appendiceal cases listed in the review had some form of metastases occurring. No observed trends have been noticed as to why this increase is occurring. One theory proposed is the increased use of computed tomography imaging in emergency departments since the early 1990s allowing for detection to occur before a surgery may be performed.
Notable cases
Actress Audrey Hepburn was diagnosed with appendiceal cancer, and died of the disease in 1993.[20] In 2007, ESPN sportscast anchor Stuart Scott was diagnosed with appendiceal cancer, and died of the disease in 2015.[21][22] Serbian musician Vlada Divljan was diagnosed with the cancer in 2012, and died of subsequent complications in 2015.[23]
References
- ^ MedStar Georgetown Cancer Institute
- ^ Rare Diseases article
- ^ MedStar Georgetown Cancer Institute
- ^ Moffitt Cancer Center
- ^ MedStar Georgetown Cancer Institute
- ^ MedStar Georgetown Cancer Institute
- ^ University of Chicago Medicine
- ^ cancer.net
- ^ MD Anderson
- ^ Rosai, Juan (2004) [1953]. "11. Gastrointestinal tract". Rosai and Ackerman's surgical pathology (9th ed.). Mosby. pp. 761–769.
- ^ Sabiston Principles of Surgery (20th ed.). p. 1308.
- ^ a b Marmor, Schelomo; Portschy, Pamela R.; Tuttle, Todd M.; Virnig, Beth A. (6 January 2015). "The Rise in Appendiceal Cancer Incidence: 2000–2009". Journal of Gastrointestinal Surgery. 19 (4): 743–750. doi:10.1007/s11605-014-2726-7.
- ^ Teixeira, Frederico José Ribeiro; Couto Netto, Sérgio Dias do; Akaishi, Eduardo Hiroshi; Utiyama, Edivaldo Massazo; Menegozzo, Carlos Augusto Metidieri; Rocha, Marcelo Cristiano (9 March 2017). "Acute appendicitis, inflammatory appendiceal mass and the risk of a hidden malignant tumor: a systematic review of the literature". World Journal of Emergency Surgery. 12 (1). doi:10.1186/s13017-017-0122-9.
- ^ Hajjar, Roy; Dubé, Pierre; Mitchell, Andrew; Sidéris, Lucas (2019). "Combined Mucinous and Neuroendocrine Tumours of the Appendix Managed with Surgical Cytoreduction and Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy". Cureus. doi:10.7759/cureus.3894. ISSN 2168-8184.
- ^ Michael Feely, Raul S. Gonzalez. "Appendix - Other tumors - Mucinous neoplasms (LAMN and HAMN)". Topic Completed: 1 October 2017. Revised: 11 December 2019
- ^ Griniatsos, J; Michail, O (2010). "Appendiceal neuroendocrine tumors: recent insights and clinical implications". World Journal of Gastrointestinal Oncology. 2 (4): 192–196. doi:10.4251/wjgo.v2.i4.192. PMC 2999180. PMID 21160597.
{{cite journal}}
: CS1 maint: unflagged free DOI (link) - ^ M. Townsend, Courtney (2012) [1969]. "51. The appendix". Sabiston (18th ed.). Elsevier. p. 1289.
- ^ McCusker, M. E.; Coté, T. R.; Clegg, L. X.; Sobin, L. H. (2002). "Primary malignant neoplasms of the appendix". Cancer. 94 (12): 3307–3312. doi:10.1002/cncr.10589. PMID 12115365.
- ^ Bailey and Love's Short Practice of Surgery (27th ed.). p. 1315.
- ^ Selim, Jocelyn (Fall 2009), "The Fairest of All", CR, vol. 4, no. 4, Philadelphia: American Association for Cancer Research, archived from the original on April 19, 2010, retrieved January 22, 2011
- ^ "Stuart Scott Says, 'F U, Cancer!'". Men's Health. Retrieved 7 January 2015.
{{cite news}}
: External link in
(help)|ref=
- ^ "Stuart Scott, ESPN's Voice of Exuberance, Dies at 49". New York Times. Retrieved 7 January 2015.
{{cite news}}
: External link in
(help)|ref=
- ^ "Vlada Divljan poručio: Nisam životno ugrožen, osećam se vrlo dobro" (in Serbian). Blic. 30 January 2015. Retrieved 10 March 2015.
Further reading
- Hamilton, S.R.; Aaltonen, L.A., eds. (2000). "Ch. 5 Tumours of the Appendix". World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System (PDF). Lyon: International Agency for Research on Cancer. Archived from the original (PDF) on 2014-05-18. Retrieved 2014-05-18.
- McGory, Marcia L.; Maggard, Melinda A.; Kang, Hakjung; O'Connell, Jessica B.; Ko, Clifford Y. (2005). "Malignancies of the appendix: Beyond case series reports". Diseases of the Colon & Rectum. 48 (12): 2264–71. doi:10.1007/s10350-005-0196-4. PMID 16258711.
{{cite journal}}
: Unknown parameter|displayauthors=
ignored (|display-authors=
suggested) (help) - O'Donnell, M.E.; Carson, J.; Garstin, W.I.H. (2006). "Surgical treatment of malignant carcinoid tumours of the appendix". International Journal of Clinical Practice. 61 (3): 431–7. doi:10.1111/j.1742-1241.2006.00875.x. PMID 16911574 – via Medscape.
- Goede, A.C.; Caplin, M.E.; Winslet, M.C. (2003). "Carcinoid tumour of the appendix". British Journal of Surgery. 90 (11): 1317–22. doi:10.1002/bjs.4375. PMID 14598408.
- Stinner, B.; Rothmund, M. (2005). "Neuroendocrine tumours (carcinoids) of the appendix". Best Practice & Research: Clinical Gastroenterology. 19 (5): 729–38. doi:10.1016/j.bpg.2005.06.003. PMID 16253897.